← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oak Therapeutics, Inc.
Lawrence, KS
$1,603,673
Total funding
4
Grants
Funding over time
peak $892.8K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,603,673 · 4
By mechanism
R44$892,787 · 1
R43$490,304 · 2
N01$220,582 · 1
Investigators at Oak Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis$892,787
R44 · FY2025 · AI
Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis$273,458
R43 · FY2023 · AI
ORAL DISSOLVING STRIPS FOR THE DELIVERY OF ISONIAZID IN CHILDREN AND ADULTS$220,582
N01 · FY2016 · AI
Novel antiretroviral therapy delivery platform for infants and young children: oral dispensable strips (ODS)$216,846
R43 · FY2022 · AI